-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Over the past few decades, coronaviruses have become a major threat to global public health.
SARS-CoV-2 is the third known coronavirus to cause fatal respiratory diseasein in humans.
the initial clinical characteristics of SARS-CoV-2 infection are nonseal, and not all suspected patients can be tested to rule out or confirm a diagnosis.
growing scientific evidence that there may be heterogeneity in routine laboratory tests, especially blood tests.
In order to solve all aspects related to SARS-CoV-2 infection in a simple and practical way, this study analyzes the history, epidemiology and pathophysiology of the virus, focusing on the hematological changes found in its laboratory diagnosis, especially in the course of the disease.
results showed that changes in laboratory tests reflected systemic inflammation and damage in patients, that lymphocytic reduction disorders could be used to distinguish patients at risk of SARS, and that changes in hemolytic patterns were associated with complications of COVID-19.
.
